Some clinical data suggested that the polymorphisms affected the capacity of pancreatic β-cells to secrete insulin rather than aggravating insulin resistance [5,8-13], possibly by impaired β-cell proinsulin-processing [14]. Here, INS is linked to Insulin resistance.